Kura Oncology, Inc. financial data

Symbol
KURA on Nasdaq
Location
San Diego, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 04 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 693% % -49%
Debt-to-equity 114% % 897%
Return On Equity -65% % -48%
Return On Assets -31% % 23%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 87,017,518 shares 12%
Common Stock, Shares, Outstanding 87,016,000 shares 12%
Entity Public Float $1,600,000,000 USD 106%
Common Stock, Value, Issued $9,000 USD 12%
Weighted Average Number of Shares Outstanding, Basic 87,645,000 shares 0.8%
Weighted Average Number of Shares Outstanding, Diluted 87,645,000 shares 0.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $20,750,000 USD
Research and Development Expense $238,933,000 USD 59%
General and Administrative Expense $104,914,000 USD 56%
Nonoperating Income (Expense) $25,178,000 USD 26%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $214,640,000 USD -36%
Income Tax Expense (Benefit) $226,000 USD
Net Income (Loss) Attributable to Parent $216,884,000 USD -9.8%
Earnings Per Share, Basic -2 USD/shares -4.7%
Earnings Per Share, Diluted -2 USD/shares -4.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $95,287,000 USD 93%
Accounts Receivable, after Allowance for Credit Loss, Current $35,936,000 USD
Assets, Current $620,663,000 USD 34%
Property, Plant and Equipment, Net $7,397,000 USD 463%
Operating Lease, Right-of-Use Asset $7,539,000 USD 24%
Other Assets, Noncurrent $13,782,000 USD 67%
Assets $649,381,000 USD 36%
Accounts Payable, Current $4,671,000 USD 55%
Employee-related Liabilities, Current $14,595,000 USD 17%
Contract with Customer, Liability, Current $48,750,000 USD
Liabilities, Current $121,304,000 USD 200%
Contract with Customer, Liability, Noncurrent $268,854,000 USD
Operating Lease, Liability, Noncurrent $8,364,000 USD 53%
Other Liabilities, Noncurrent $2,981,000 USD 103%
Liabilities $406,839,000 USD 639%
Accumulated Other Comprehensive Income (Loss), Net of Tax $711,000 USD
Retained Earnings (Accumulated Deficit) $1,093,089,000 USD -25%
Stockholders' Equity Attributable to Parent $242,542,000 USD -43%
Liabilities and Equity $649,381,000 USD 36%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $71,927,000 USD -47%
Net Cash Provided by (Used in) Financing Activities $143,000 USD
Net Cash Provided by (Used in) Investing Activities $101,409,000 USD -6.4%
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 87,016,000 shares 12%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $173,193,000 USD -4235%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $95,287,000 USD 93%
Deferred Tax Assets, Valuation Allowance $278,859,000 USD 24%
Deferred Tax Assets, Gross $280,516,000 USD 24%
Operating Lease, Liability $9,793,000 USD 37%
Depreciation $241,000 USD 3%
Payments to Acquire Property, Plant, and Equipment $292,000 USD 248%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $217,082,000 USD -13%
Lessee, Operating Lease, Liability, to be Paid $24,460,000 USD 142%
Property, Plant and Equipment, Gross $11,265,000 USD 157%
Operating Lease, Liability, Current $1,429,000 USD -15%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,533,000 USD 14%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,533,000 USD -22%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 8.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $8,835,000 USD 201%
Lessee, Operating Lease, Liability, to be Paid, Year Three $3,658,000 USD 167%
Deferred Tax Assets, Operating Loss Carryforwards $97,605,000 USD -32%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $15,447,000 USD 53%
Lessee, Operating Lease, Liability, to be Paid, Year Four $3,754,000 USD 169%
Operating Lease, Payments $1,500,000 USD 67%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense $10,965,000 USD 32%
Interest Expense $1,602,000 USD 4.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%